Name: Allergan PLC (NYSE:AGN) | Statement of Comprehensive Income
Creator: Stock Analysis on Net

Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Download chart

Allergan PLC, consolidated statement of comprehensive income

US$ in thousands

12 months ended:	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Net income (loss)	(5,265,100)	(5,086,200)	(4,118,900)	14,979,500)	3,919,400)
Foreign currency translation gains (losses)	(151,800)	(474,400)	1,248,000)	(441,600)	(129,900)
Net impact of other-than-temporary loss on investment in Teva securities	—)	—)	1,599,400)	—)	—)
Impact of Teva Transaction	—)	—)	—)	1,544,800)	—)
Unrealized gains (losses), net of tax	13,800)	(38,100)	111,700)	(1,647,500)	101,200)
Other comprehensive income (loss), net of tax	(138,000)	(512,500)	2,959,100)	(544,300)	(28,700)
Comprehensive income (loss)	(5,403,100)	(5,598,700)	(1,159,800)	14,435,200)	3,890,700)
Comprehensive income attributable to noncontrolling interest	(5,900)	(10,200)	(6,600)	(6,100)	(4,200)
Comprehensive income (loss) attributable to ordinary shareholders	(5,409,000)	(5,608,900)	(1,166,400)	14,429,100)	3,886,500)

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

The financial performance between 2015 and 2019 is characterized by extreme volatility, moving from a period of significant profitability to a sustained trend of comprehensive losses.

Net Income Trends: Net income experienced a sharp increase in 2016, peaking at 14.98 billion USD. This was followed by a severe reversal in 2017, where the company shifted to a net loss of 4.12 billion USD. This downward trajectory continued through 2019, with net losses widening to 5.27 billion USD.
Other Comprehensive Income (OCI) Analysis: OCI exhibited significant fluctuations, largely driven by foreign currency translations and specific investment impacts. A substantial positive spike was recorded in 2017, reaching 2.96 billion USD, which was primarily supported by a 1.25 billion USD gain in foreign currency translation and a 1.60 billion USD impact related to Teva securities. Conversely, unrealized gains and losses remained volatile, contributing negatively in 2016 and 2018.
Comprehensive Income Trajectory: The total comprehensive income mirrors the volatility of net income, with a high of 14.44 billion USD in 2016 followed by a transition into deficits. The comprehensive loss expanded from 1.16 billion USD in 2017 to 5.40 billion USD by 2019, indicating a persistent erosion of comprehensive value over the latter three years of the period.
Shareholder Attribution: The vast majority of the comprehensive income and subsequent losses were attributable to ordinary shareholders. Comprehensive income attributable to noncontrolling interests remained marginal and consistently negative, ranging from 4.2 million to 10.2 million USD, suggesting that equity holders bore nearly the entire weight of the financial volatility.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?